<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of Pharmacy and Health Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPHR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2321-3647</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">AJPHR210010</article-id>
      <title-group>
        <article-title>A Validated Stability Indicating RP-UPLC Method for the Quantitative Determination of Potential Impurities of Allopurinol</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>PG</surname>
            <given-names>Sajan</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>T</surname>
            <given-names>Rohith</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Patil</surname>
            <given-names>Santosh</given-names>
          </name>
          <xref ref-type="aff" rid="aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>K</surname>
            <given-names>Mantelingu</given-names>
          </name>
          <xref ref-type="aff" rid="aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>S</surname>
            <given-names>Rangappa K</given-names>
          </name>
          <xref ref-type="aff" rid="aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>N</surname>
            <given-names>Kumara M</given-names>
          </name>
          <xref ref-type="aff" rid="aff4"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">Deepta Laboratories, No.77-78/1, Vishweshwaranagar, 2nd stage, Industrial Suburb, Mysore – 570008</aff>
      <aff id="aff2">Biocon Limited, Plot No. 2,3,4,5 &amp; 6, Bommasandra Jigani Link Road, Bangalore, 560099</aff>
      <aff id="aff3">Department of Chemistry, Manasagangothri, University of Mysore, Mysore-570006</aff>
      <aff id="aff4">Chemistry department, Yuvaraja’s college, University of Mysore, Mysore-570005</aff>
      <pub-date pub-type="epub" iso-8601-date="2014-10-01">
        <month>10</month>
        <day>01</day>
        <year>2014</year>
      </pub-date>
      <volume>2</volume>
      <issue>10</issue>
      <abstract>
        <p>A simple, sensitive, selective and stability indicating UPLC method has been developed for the quantitative determination of potential impurities of allopurinol active pharmaceutical ingredient. Allopurinol, its five impurities and degradation products were separated efficiently by using the mobile phase consisted of sodium perchlorate (10 mM, pH 3.0)and acetonitrile on a HSS T3P stationary phase in gradient elution profile. Forced degradation study confirmed that the newly developed method was specific and selective to the degradation products. The newly developed UPLC method was validated according to ICH guidelines considering five impurities to demonstrate specificity, precision, linearity, accuracy and stability indicating nature of the method. Regression analysis showed correlation coefficient value greater than 0.99 for allopurinol and its five impurities. Detection limit of impurities was in the range of 0.002–0.006% indicating the high sensitivity of the newly developed method. Accuracy of the method was established based on the recovery obtained between 91.7% and 106.6% for all impurities.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Allopurinol</kwd>
        <kwd>Impurities</kwd>
        <kwd>RP-UPLC</kwd>
        <kwd>Validation</kwd>
        <kwd>Forced Degradation.</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
